LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 247

Search options

  1. Book ; Conference proceedings: Translating today's science into clinical practice

    Barter, Philip J.

    proceedings of the Future Forum Conference, Budapest, Hungary, May 2005

    (Atherosclerosis : Supplements ; 7,1)

    2006  

    Event/congress Future Forum Conference (2005, Budapest)
    Author's details chaired by: Philip Barter
    Series title Atherosclerosis : Supplements ; 7,1
    Atherosclerosis
    Atherosclerosis ; Supplements
    Collection Atherosclerosis
    Atherosclerosis ; Supplements
    Language English
    Size 49 S. : Ill., graph. Darst.
    Publisher Elsevier
    Publishing place Amsterdam u.a.
    Publishing country Netherlands
    Document type Book ; Conference proceedings
    HBZ-ID HT014737650
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  2. Book ; Conference proceedings: Cardiovascular risk through the ages

    Barter, Philip J.

    proceedings of the Future Forum Conference held in Noordwijk, The Netherlands, October 2003 ; defining global standards in metabolic and vascular diseases

    (Atherosclerosis : Supplements ; 5,2)

    2004  

    Event/congress Future Forum Conference (2003, Noordwijk)
    Author's details chaired by Philip Barter
    Series title Atherosclerosis : Supplements ; 5,2
    Atherosclerosis
    Atherosclerosis ; Supplements
    Collection Atherosclerosis
    Atherosclerosis ; Supplements
    Language English
    Size 42 S. : Ill., graph. Darst.
    Publisher Elsevier
    Publishing place Amsterdam u.a.
    Publishing country Netherlands
    Document type Book ; Conference proceedings
    HBZ-ID HT014024525
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  3. Article ; Online: High- Versus Low-Dose Statin: Effects on Cardiovascular Events and All-Cause Death.

    Barter, Philip J

    Circulation

    2018  Volume 137, Issue 19, Page(s) 2013–2015

    MeSH term(s) Coronary Artery Disease ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Quinolines ; Simvastatin
    Chemical Substances Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Quinolines ; Simvastatin (AGG2FN16EV) ; pitavastatin (M5681Q5F9P)
    Language English
    Publishing date 2018-04-18
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 80099-5
    ISSN 1524-4539 ; 0009-7322 ; 0069-4193 ; 0065-8499
    ISSN (online) 1524-4539
    ISSN 0009-7322 ; 0069-4193 ; 0065-8499
    DOI 10.1161/CIRCULATIONAHA.118.034407
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book ; Conference proceedings: Lipids, inflammation and CVD - understanding the basics to break the atherosclerosis cycle

    Barter, Philip J.

    proceedings of the future forum virtual conference, May 2003

    (International journal of clinical practice : Supplement ; 137)

    2003  

    Author's details chaired by: Philip Barter
    Series title International journal of clinical practice : Supplement ; 137
    The International journal of clinical practice
    International journal of clinical practice ; Supplement
    Collection The International journal of clinical practice
    International journal of clinical practice ; Supplement
    Language English
    Size 43 S. : graph. Darst.
    Publisher Medicom International
    Publishing place Esher, Surrey
    Publishing country Great Britain
    Document type Book ; Conference proceedings
    HBZ-ID HT013846378
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  5. Book ; Conference proceedings: In a modern world, atherosclerosis is an almost evolutionary certainty

    Barter, Philip J.

    proceedings of the Future Forum Conference held in Monte Carlo, October 2002

    (International journal of clinical practice : Supplement ; 134)

    2003  

    Institution Future Forum Conference
    Author's details chaired by: Philip Berter
    Series title International journal of clinical practice : Supplement ; 134
    The International journal of clinical practice
    International journal of clinical practice ; Supplement
    Collection The International journal of clinical practice
    International journal of clinical practice ; Supplement
    Language English
    Size 57 S. : Ill., graph. Darst.
    Publisher Medicom International
    Publishing place Esher, Surrey
    Publishing country Great Britain
    Document type Book ; Conference proceedings
    HBZ-ID HT013665497
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  6. Book: Plasma lipids and their role in disease

    Barter, Philip J.

    (Advances in vascular biology ; 5)

    1999  

    Author's details ed. by Philip J. Barter
    Series title Advances in vascular biology ; 5
    Collection
    Language English
    Size XIII, 352 S. : Ill., graph. Darst.
    Publisher Harwood Acad. Publ
    Publishing place Amsterdam
    Publishing country Netherlands
    Document type Book
    HBZ-ID HT012737671
    ISBN 90-5702-466-7 ; 978-90-5702-466-5
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  7. Book: High density cholesterol

    Barter, Philip J. / Rye, Kerry-Anne

    the new target ; a handbook for clinicians

    (Therapeutic guides)

    2005  

    Author's details Philip Barter ; Kerry-Anne Rye
    Series title Therapeutic guides
    Keywords Cholesterol ; High density lipoproteins ; Coronary heart disease/Prevention
    Subject code 572.5795
    Language English
    Size 92 S. : Ill., graph. Darst., 26cm
    Edition 2. ed.
    Publisher Sherborne Gibbs
    Publishing place Birmingham
    Publishing country Great Britain
    Document type Book
    Note Includes bibliographical references
    HBZ-ID HT014838325
    ISBN 1-905036-05-1 ; 978-1-905036-05-9
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  8. Article ; Online: HDL Cholesterol Level and Mortality Occurrence in the Elderly: Is the Good Cholesterol Always Good?

    Santos, Raul D / Barter, Philip J

    The Journal of clinical endocrinology and metabolism

    2019  Volume 104, Issue 9, Page(s) 4114–4116

    Language English
    Publishing date 2019-05-17
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3029-6
    ISSN 1945-7197 ; 0021-972X
    ISSN (online) 1945-7197
    ISSN 0021-972X
    DOI 10.1210/jc.2019-00845
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Cholesteryl Ester Transfer Protein Inhibitors as Agents to Reduce Coronary Heart Disease Risk.

    Barter, Philip J / Rye, Kerry-Anne

    Cardiology clinics

    2018  Volume 36, Issue 2, Page(s) 299–310

    Abstract: Cholesteryl ester transfer protein (CETP) promotes the transfer of cholesteryl esters from the nonatherogenic high density lipoprotein (HDL) fraction to potentially proatherogenic non-HDL fractions. Inhibition of CETP reduces the concentration of non-HDL ...

    Abstract Cholesteryl ester transfer protein (CETP) promotes the transfer of cholesteryl esters from the nonatherogenic high density lipoprotein (HDL) fraction to potentially proatherogenic non-HDL fractions. Inhibition of CETP reduces the concentration of non-HDL cholesterol, enhances HDL functionality, and increases the concentration of HDL cholesterol and apoA-I. Despite an absence of benefit in earlier trials of CETP inhibition, the REVEAL trial has shown that treatment with the CETP inhibitor anacetrapib reduces the risk of having a coronary event in high-risk, statin-treated patients.
    MeSH term(s) Anticholesteremic Agents/therapeutic use ; Cholesterol Ester Transfer Proteins/antagonists & inhibitors ; Cholesterol Ester Transfer Proteins/blood ; Coronary Disease/blood ; Coronary Disease/epidemiology ; Coronary Disease/prevention & control ; Global Health ; Humans ; Incidence ; Prognosis
    Chemical Substances Anticholesteremic Agents ; Cholesterol Ester Transfer Proteins
    Language English
    Publishing date 2018-02-16
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 1196385-2
    ISSN 1558-2264 ; 0733-8651
    ISSN (online) 1558-2264
    ISSN 0733-8651
    DOI 10.1016/j.ccl.2017.12.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Variations in time to benefit among clinical trials of cholesterol-lowering drugs.

    Barter, Philip J / Waters, David D

    Journal of clinical lipidology

    2018  Volume 12, Issue 4, Page(s) 857–862

    Abstract: Background: Time to benefit (TTB) in clinical trials of cholesterol-lowering drugs is important because it may provide a clue as to the potential mechanism of action of the drug, it is helpful in determining when to stop a trial for futility, and it may ...

    Abstract Background: Time to benefit (TTB) in clinical trials of cholesterol-lowering drugs is important because it may provide a clue as to the potential mechanism of action of the drug, it is helpful in determining when to stop a trial for futility, and it may inform treatment decisions in subjects with reduced life expectancy.
    Objective: To compare TTB among clinical trials of cholesterol-lowering drugs.
    Methods: We examined TTB in 24 trials of cholesterol-lowering drugs with positive outcomes. Benefit curves were constructed by subtracting the curve for a placebo or comparator drug from the curve for active treatment.
    Results: TTB ranged from 1 to 30 (mean 13.1) months, being shorter in trials of statins (n = 17) compared to nonstatins (n = 7), 10.3 vs 20.0 months. Among statin trials, TTB was shorter with atorvastatin (n = 6) than in trials with other statins (n = 11), 4.75 compared to 11.4 months.
    Conclusions: TTB is variable among trials of cholesterol-lowering drugs, being shorter with statin compared to nonstatin drugs. TTB is shorter with atorvastatin than with other statins. For trials of new cholesterol-lowering drugs, outcome curves that do not separate for up to 30 months do not preclude eventual benefit.
    MeSH term(s) Anticholesteremic Agents/therapeutic use ; Cholesterol, LDL/blood ; Clinical Trials as Topic ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Hypercholesterolemia/drug therapy ; Hypercholesterolemia/pathology ; Risk Assessment
    Chemical Substances Anticholesteremic Agents ; Cholesterol, LDL ; Hydroxymethylglutaryl-CoA Reductase Inhibitors
    Language English
    Publishing date 2018-04-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2365061-8
    ISSN 1876-4789 ; 1933-2874
    ISSN (online) 1876-4789
    ISSN 1933-2874
    DOI 10.1016/j.jacl.2018.04.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top